Fairfax Financial Holdings Portfolio Declines to 1.94 Billion

Prem Watsa’s Fairfax Financial Holdings reported its Q1 2026 13F portfolio at 1.94 billion dollars after a decline. The filing showed a full exit from Occidental Petroleum and increased stakes in Under Armour and Kraft Heinz. Top positions remained concentrated in Orla Mining, Under Armour, and CVS Health.

The 13F form, filed on May 15 2026, detailed significant shifts in the equity holdings. Fairfax disposed of its entire position in Occidental Petroleum while adding aggressively to Under Armour and Kraft Heinz. Smaller increases went to Molson Coors and Pfizer. Orla Mining continued to represent about 26 percent of the portfolio and CVS Health about 10 percent, together with Under Armour making up roughly 55 percent of the total. Positions in Kennedy-Wilson and BlackBerry saw only minor changes. The equity holdings form a small part of Fairfax’s overall 73 billion dollar portfolio. Shares of FRFHF traded near 1614 dollars, above the reported Q1 2026 book value of about 1250 dollars.

Awọn iroyin ti o ni ibatan

Split-scene illustration of BSE trading floor showing high-priced stocks' divergent FY26 performance: laggards crashing amid global tensions, gainers surging.
Àwòrán tí AI ṣe

High-priced BSE stocks diverge in FY26 performance

Ti AI ṣe iroyin Àwòrán tí AI ṣe

Among 68 high-priced stocks trading above Rs 5,000 on the BSE, FY26 has brought more declines than gains amid global uncertainty and geopolitical tensions. The top six laggards fell 25-40%, while top gainers surged 40-130%. Institutional holdings vary across these stocks.

Ruane, Cunniff & Goldfarb disclosed a first-quarter 2026 portfolio valued at 6.03 billion dollars across 50 holdings. The top three positions made up about 31 percent of assets. New stakes were added in Sunbelt Rentals Holdings and Zoetis.

Ti AI ṣe iroyin

Fairholme Fund's 13F portfolio increased to approximately $1.43 billion in Q4 2025, with about 80% allocated to St. Joe Company. The update reflects a concentrated, long-term investment strategy. New minor positions were added in several companies, while others saw small reductions.

Goldman Sachs’ Indian equity portfolio, managed through its global funds, dropped 36% in the fiscal year ending March 2026, shrinking from Rs 11,940 crore to Rs 7,610 crore as of March 27. While about 28 of its roughly 48 stocks declined between 10% and 60%, with five major holdings losing over 50%, one standout performer delivered 107% gains.

Ti AI ṣe iroyin

Night Watch Investment Management LP reported a 2.69% appreciation net of fees for the first quarter of 2026. The firm navigated market volatility driven by AI narratives and the war in Iran, highlighting strong performances from positions like Brookdale and AAR Corp. Its portfolio emphasizes resilient businesses amid geopolitical tensions.

The Western Asset Inflation-Linked Opportunities & Income Fund (WIW) delivered a 13.09% market price return over the past year, despite fixed-income market volatility in the fourth quarter of 2025. Its NAV return stood at 9.34% for the same period.

Ti AI ṣe iroyin

Indian fund managers directed fresh investments into pharmaceutical and non-banking financial companies during April. The moves targeted defensive stocks amid concerns over oil prices and tensions in West Asia.

 

 

 

Ojú-ìwé yìí nlo kuki

A nlo kuki fun itupalẹ lati mu ilọsiwaju wa. Ka ìlànà àṣírí wa fun alaye siwaju sii.
Kọ